Genomictree, Inc. (228760) Price & Analysis

― Followers

228760 Stock Chart & Stats

₩10460.00

-₩790.00(-7.02%)

Jul 29, 2026

―

Day’s Range― - ―

52-Week Range₩10,010.00 - ₩33,300.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)97.08K

Market Cap

₩275.62B

Enterprise ValueN/A

Total Cash (Recent Filing)₩75.39B

Total Debt (Recent Filing)₩55.19M

Price to Earnings (P/E)―

Beta0.05

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-334.06

Shares Outstanding24,859,201

10 Day Avg. Volume118,684

30 Day Avg. Volume97,075

Financial Highlights & Ratios

PEG Ratio3.41

Price to Book (P/B)3.59

Price to Sales (P/S)109.82

P/FCF Ratio-41.42

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-212,922.17

Revenue Forecast (FY)₩11.45T

228760 FAQ

What was Genomictree, Inc.’s price range in the past 12 months?

Genomictree, Inc. lowest stock price was ₩10010.00 and its highest was ₩33300.00 in the past 12 months.

What is Genomictree, Inc.’s market cap?

Genomictree, Inc.’s market cap is ₩275.62B.

When is Genomictree, Inc.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Genomictree, Inc.’s earnings last quarter?

Genomictree, Inc. released its earnings results on May 15, 2026. The company reported -₩80.205 earnings per share for the quarter, missing the consensus estimate of N/A by -₩80.205.

Is Genomictree, Inc. overvalued?

According to Wall Street analysts Genomictree, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Genomictree, Inc. pay dividends?

Genomictree, Inc. does not currently pay dividends.

What is Genomictree, Inc.’s EPS estimate?

Genomictree, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Genomictree, Inc. have?

Genomictree, Inc. has 24,859,201 shares outstanding.

What happened to Genomictree, Inc.’s price movement after its last earnings report?

Genomictree, Inc. reported an EPS of -₩80.205 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.786%.

Which hedge fund is a major shareholder of Genomictree, Inc.?

Currently, no hedge funds are holding shares in KR:228760

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Genomictree, Inc.

Genomictree Inc is a molecular diagnostics firm focused on innovating technologies that address critical, unmet demands within the healthcare industry.